The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?
Open accessAbstract
Patients with chronic kidney disease (CKD) are at an increased risk of premature mortality, mainly from cardiovascular causes. The association between CKD on hemodialysis and accelerated atherosclerosis was described >40 years ago. However, more recently, it has been suggested that the increase in atherosclerosis risk is actually observed in early CKD stages, remaining stable thereafter. In this regard, interventions targeting the pathogenesis of atherosclerosis, such as statins, successful in the general population, have failed to benefit patients with very advanced CKD. This raises the issue of the relative contribution of atherosclerosis versus other forms of cardiovascular injury such as arteriosclerosis or myocardial injury to the increased cardiovascular risk in CKD. In this review, the pathophysiogical contributors to atherosclerosis in CKD that are shared with the general population, or specific to CKD, are discussed. The NEFRONA study (Observatorio Nacional de Atherosclerosis en NEFrologia) prospectively assessed the prevalence and progression of subclinical atherosclerosis (plaque in vascular ultrasound), confirming an increased prevalence of atherosclerosis in patients with moderate CKD. However, the adjusted odds ratio for subclinical atherosclerosis increased with CKD stage, suggesting a contribution of CKD itself to subclinical atherosclerosis. Progression of atherosclerosis was closely related to CKD progression as well as to the baseline presence of atheroma plaque, and to higher phosphate, uric acid, and ferritin and lower 25(OH) vitamin D levels. These insights may help design future clinical trials of stratified personalized medicine targeting atherosclerosis in patients with CKD. Future primary prevention trials should enroll patients with evidence of subclinical atherosclerosis and should provide a comprehensive control of all known risk factors in addition to testing any additional intervention or placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Renal function, atherothrombosis extent, and outcomes in high-risk patients
Dumaine, R. L., Montalescot, G., Steg, P. G., Ohman, E. M., Eagle, K. A., & Bhatt, D. L. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.05.011 · Cited by 56
Kidney Disease, Framingham Risk Scores, and Cardiac and Mortality Outcomes
Weiner, D. E., Tighiouart, H., Griffith, J. L., Elsayed, E. F., Levey, A. S., Salem, D. N., & Sarnak, M. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.05.054 · Cited by 55
New perspectives on CKD-induced dyslipidemia
Bermúdez-López, M., Arroyo, D., Betriu, À., Masana, L., Fernández, E., & Valdivielso, J. M. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1369961 · Cited by 54
Self-citationInterventions for lowering plasma homocysteine levels in dialysis patients
Nigwekar, S. U., Kang, A., Zoungas, S., Cass, A., Gallagher, M., Kulshrestha, S., Navaneethan, S. D., Perkovic, V., Strippoli, G. F., & Jardine, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004683.pub4 · Cited by 53
Chen, Y., Su, Y., Lee, C., Huang, Y.-S., & Hwang, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036332 · Cited by 53
Maftei, O., Peña, A. S., Sullivan, T., Jones, T. W., Donaghue, K. C., Cameron, F. J., Davis, E. A., Cotterill, A. M., Craig, M. E., Gent, R. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0700 · Cited by 53
Berg, M., Bhatt, D. L., Kappelle, L. J., de Borst, G. J., Cramer, M. J., van der Graaf, Y., Steg, P. G., Visseren, F. L. J., on behalf of the SMART study group, & REACH Registry investigators (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx102 · Cited by 48
Khandelwal, P., Murugan, V., Hari, S., Ramakrishnan, L., Sinha, A. P., Hari, P., & Bagga, A. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3350-4 · Cited by 47
Glomerular filtration rate is related to carotid intima-media thickness in middle-aged adults
Kastarinen, H., Ukkola, O. H., & Kesäniemi, Y. A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp172 · Cited by 46
Uraemic dyslipidaemia revisited: role of high-density lipoprotein
Speer, T., Zewinger, S., & Fliser, D. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft080 · Cited by 45
The effect of chronic kidney disease on lipid metabolism
Dinçer, N., Dağel, T., Afşar, B., Covic, A. C., Ortíz, A., & Kanbay, M. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-2047-y · Cited by 45
Matsunaga, S., Okigaki, M., Takeda, M., Matsui, A., Honsho, S., Katsume, A., Kishita, E., Che, J., Kurihara, T., Adachi, Y., et al. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.01.015 · Cited by 43
Atheroma Progression in Chronic Kidney Disease
Rigatto, C., Levin, A., House, A. A., Barrett, B. J., Carlisle, E., & Fine, A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01840408 · Cited by 43
Mary, A., Hénaut, L., Boudot, C., Six, I., Brazier, M., Massy, Z. A., Drüeke, T. B., Kamel, S., & Mentaverri, R. (2015) · Endocrinology · doi:10.1210/en.2014-1744 · Cited by 43
Božić, M., Panizo, S., Sevilla, M. A., Riera, M., Soler, M. J., Pascual, J., Lopez, I., Freixenet, M., Fernández, E., & Valdivielso, J. M. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000261 · Cited by 43
Self-citationSchwaiger, J. P., Lamina, C., Neyer, U., König, P., Kathrein, H., Sturm, W., Lhotta, K., Gröchenig, E., Dieplinger, H., & Kronenberg, F. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.01.011 · Cited by 42
Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1
Zuo, Y., Yancey, P. G., Castro, I., Khan, W. N., Motojima, M., Ichikawa, I., Fogo, A. B., Linton, M. F., Fazio, S., & Kon, V. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.188995 · Cited by 42
Chen, H., Fang, W., Wang, L., Wang, Z., Meng, J., Yu, H., Zhang, R., Sun, G., Jiang, A., & Wang, L. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0376-z · Cited by 42
Martín, M., Valls, J., Betriu, À., Fernández, E., & Valdivielso, J. M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.02.048 · Cited by 41
Self-citationYamamoto, S., Zhong, J., Yancey, P. G., Zuo, Y., Linton, M. F., Fazio, S., Yang, H., Narita, I., & Kon, V. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.055 · Cited by 41
Lipid Management in Chronic Kidney Disease: Systematic Review of PCSK9 Targeting
Zheng-Lin, B., & Ortíz, A. (2018) · Drugs · doi:10.1007/s40265-017-0858-2 · Cited by 41
Silbernagel, G., Fauler, G., Genser, B., Drechsler, C., Krane, V., Scharnagl, H., Grammer, T. B., Baumgärtner, I., Ritz, E., Wanner, C., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.551 · Cited by 40
Zeng, L., Mathew, A. V., Byun, J., Atkins, K. B., Brosius, F. C., & Pennathur, S. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000559 · Cited by 40
Association Between the Ankle-Brachial Index and Future Coronary Calcium (The Rancho Bernardo Study)
Allison, M., Laughlin, G. A., Barrett-Connor, E. L., & Langer, R. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.019 · Cited by 38
Pérez, H. A., Garcia, N. H., Spence, J. D., & Armando, L. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59924 · Cited by 38
Anguiano, L., Riera, M., Pascual, J., Valdivielso, J. M., Barrios, C., Betriu, À., Clotet, S., Mojal, S., Fernández, E., & Soler, M. J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.032 · Cited by 38
Self-citationDyslipidemia in Dialysis Patients
Qunibi, W. Y. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12375 · Cited by 34
Khalique, O. K., Aronow, W. S., Ahn, C. W., Mazar, M., Schair, B., Shao, J. H., & Channamsetty, V. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.038 · Cited by 32
Low ankle-brachial index and risk of stroke
Fan, H., Hu, X., Yu, W., Cao, H., Wang, J., Li, J., Liu, B., Yang, J., & Zhang, Q. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.014 · Cited by 32
Fort, J., Cuevas, X. D. L., López, F. J. G., Pérez‐García, R., Llados, F., Lozano, J., Martín‐Malo, A., & on behalf of all investigators from the ANSWER study (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq073 · Cited by 32
Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area
Shah, N. H., Dong, C., Elkind, M. S. V., Sacco, R. L., Mendez, A. J., Hudson, B. I., Silverberg, S. J., Wolf, M. S., Rundek, T., & Wright, C. B. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305945 · Cited by 32
Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction
Suganuma, E., Zuo, Y., Ayabe, N., Ma, J., Babaev, V. R., Linton, M. F., Fazio, S., Ichikawa, I., Fogo, A. B., & Kon, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080883 · Cited by 32
Nordlohne, J., Helmke, A., Ge, S., Rong, S., Chen, R., Waisman, A., Haller, H. G., & von Vietinghoff, S. (2018) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.08.005 · Cited by 32
Qu, B., Liu, Q., & Li, J. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0582-z · Cited by 31
Renal function and carotid atherosclerosis in adults with no known kidney disease
Buscemi, S., Geraci, G., Massenti, F. M., Buscemi, C., Costa, F. D., D'Orio, C., Rosafio, G., Buscemi, C., Maniaci, V., & Parrinello, G. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.09.013 · Cited by 31
He, X., Hu, X., Ma, X., Su, H., Ying, L., Peng, J., Pan, X., Bao, Y., Zhou, J., & Jia, W. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0559-x · Cited by 31
Yılmaz, R., Altun, B., Kahraman, S., Ozer, N., Akıncı, D., & Turgan, Ç. (2010) · Renal Failure · doi:10.3109/0886022x.2010.502276 · Cited by 30
Valdivielso, J. M., Betriu, À., Martínez‐Alonso, M., Arroyo, D., Bermúdez-López, M., Fernández, E., & for the NEFRONA investigators (2017) · PLoS ONE · doi:10.1371/journal.pone.0186665 · Cited by 30
Self-citationKawahito, H., Yamada, H., Irie, D., Kato, T., Akakabe, Y., Kishida, S., Takata, H., Wakana, N., Ogata, T., Ikeda, K., et al. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00053.2013 · Cited by 29
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease
Sharif, M., Campanholle, G., Nagiec, E. E., Wang, J., Syed, J., O’Neil, S. P., Zhan, Y., Brenneman, K. A., Homer, B., Neubert, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155368 · Cited by 29
MicroRNA-142-3p improves vascular relaxation in uremia
Kétszeri, M., Kirsch, A., Frauscher, B., Moschovaki-Filippidou, F., Mooslechner, A. A., Kirsch, A. H., Schabhüttl, C., Aringer, I., Artinger, K., Pregartner, G., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.11.024 · Cited by 29
Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease
Barrios, C., Pascual, J., Otero, S., Soler, M. J., Rodríguez, E., Collado, S., Faura, A., Mojal, S., Navarro‐González, J. F., Betriu, À., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.048 · Cited by 28
Self-citationBožić, M., Méndez‐Barbero, N., Gutiérrez‐Muñoz, C., Betriu, À., Egido, J., Fernández, E., Martı́n-Ventura, J. L., Valdivielso, J. M., & Blanco‐Colio, L. M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.011 · Cited by 28
Self-citationEffect of Lisinopril and Atenolol on Aortic Stiffness in Patients on Hemodialysis
Georgianos, P. I., & Agarwal, R. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09981014 · Cited by 27
Fakhry, M., Skafi, N., Fayyad‐Kazan, M., Kobeissy, F. H., Hamade, E., Mebarek, S., Habib, A., Borghol, N., Zeidan, A., Magne, D., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26121 · Cited by 27
Management of hypertension in patients with chronic kidney disease
Hamrahian, S. M. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0739-9 · Cited by 26
Hu, X., Ma, X., Luo, Y., Xu, Y., Xiong, Q., Pan, X., Bao, Y., & Jia, W. (2016) · Scientific Reports · doi:10.1038/srep34696 · Cited by 24
Villa‐Bellosta, R., Rodríguez-Osorio, L., Mas, S., Abadi, Y., Rubert, M., de la Piedra, C., Gracia-Iguacel, C., Mahíllo, I., Ortíz, A., Egido, J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173831 · Cited by 23
Sedlis, S. P., Jurkovitz, C. T., Hartigan, P. M., Kolm, P., Goldfarb, D. S., Lorin, J. D., Dada, M. R., Maron, D. J., Spertus, J. A., Mancini, G. B. J., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.07.034 · Cited by 22
Bleeding in advanced CKD patients on antithrombotic medication – A critical appraisal
Burlacu, A., Genovesi, S., Goldsmith, D. J. A., Rossignol, P., Ortíz, A., Kalra, P. A., Małyszko, J., Banach, M., Kanbay, M., & Covic, A. C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.004 · Cited by 22
Role of vitamin D receptor activators on cardiovascular risk
Valdivielso, J. M., & Ayus, J. C. (2008) · Kidney International · doi:10.1038/ki.2008.545 · Cited by 21
Self-citationGonzález‐Parra, E., Aceña, Á., Lorenzo, Ó., Tarín, N., González‐Casaus, M. L., Cristóbal, C., Huelmos, A. I., Mahíllo, I., Pello, A. M., Carda, R., et al. (2015) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-015-0706-y · Cited by 20
Vitamin D and the vasculature: can we teach an old drug new tricks?
Valdivielso, J. M., Coll, B., & Fernández, E. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220802564390 · Cited by 20
Self-citationAbajo, M., Betriu, À., Arroyo, D., Gracia, M., y Pino, M. D. D. P., Martínez, I., Valdivielso, J. M., Fernández, E., & on behalf of the investigators of the NEFRONA study (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw306 · Cited by 20
Self-citationLipoprotein(a) accelerates atherosclerosis in uremic mice
Pedersen, T. X., McCormick, S. P. A., Tsimikas, S., Bro, S., & Nielsen, L. B. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006742 · Cited by 19
Collado, S., Coll, E., Nicolau, C., Pons, M., Cruzado, J. M., Pascual, J., & Cases, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127344 · Cited by 19
Self-citationCovic, A. C., Genovesi, S., Rossignol, P., Kalra, P. A., Ortíz, A., Banach, M., & Burlacu, A. (2018) · BMC Medicine · doi:10.1186/s12916-018-1145-0 · Cited by 19
Moderate kidney disease inhibits atherosclerosis regression
Ponda, M. P., Barash, I., Feig, J. E., Fisher, E. A. A., & Skolnik, E. Y. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.029 · Cited by 18
Burlacu, A., Genovesi, S., Ortíz, A., Kanbay, M., Rossignol, P., Banach, M., Małyszko, J., Goldsmith, D. J. A., & Covic, A. C. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx041 · Cited by 18
Arcidiacono, M. V., Rimondi, E., Maietti, E., Melloni, E., Tisato, V., Gallo, S., Valdivielso, J. M., Fernández, E., Betriu, À., Voltan, R., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203716 · Cited by 18
Self-citationRelationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease
Hsu, S., Rifkin, D. E., Criqui, M. H., Suder, N. C., Garimella, P. S., Ginsberg, C., Marasco, A. M., McQuaide, B. J., Barinas‐Mitchell, E., Allison, M., et al. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.09.048 · Cited by 17
Humble kidneys predict mighty heart troubles
Ortíz, A., & Fernández‐Fernández, B. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00092-3 · Cited by 16
Yamada, H., Kuro‐o, M., Hara, K., Ueda, Y., Kusaka, I., Kakei, M., & Ishikawa, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160782 · Cited by 16
Association of FGF-2 Concentrations with Atheroma Progression in Chronic Kidney Disease Patients
Božić, M., Betriu, À., Bermúdez-López, M., Ortíz, A., Fernández, E., Valdivielso, J. M., & on behalf of the NEFRONA investigators (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07980717 · Cited by 16
Self-citationMás allá de los parámetros lipídicos tradicionales en la enfermedad renal crónica
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología · doi:10.1016/j.nefro.2017.09.008 · Cited by 13
Self-citationBorràs, M., Cambray, S., Crespo‐Masip, M., Fontán, M. P., Božić, M., Bermúdez-López, M., Fernández, E., Betriu, À., & Valdivielso, J. M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01743 · Cited by 13
Self-citationHu, X., Ma, X., Luo, Y., Xu, Y., Xiong, Q., Pan, X., Bao, Y., & Jia, W. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.11.009 · Cited by 11
Beyond the traditional lipid parameters in chronic kidney disease
Bermúdez-López, M., Betriu, À., Valdivielso, J. M., del Pino, T. B., Arroyo, D., & Fernández, E. (2017) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2017.11.016 · Cited by 8
Self-citationNezami, N., Ghabili, K., Shokouhi, B., Mirchi, M., Ghojazadeh, M., Safa, J., Zomorrodi, A., Gharadaghi, A., Mojadidi, M. K., Tarzamni, M. K., et al. (2018) · The Nephron journals/Nephron journals · doi:10.1159/000487491 · Cited by 6
Berg, M., Westerink, J., van der Graaf, Y., Kappelle, L. J., de Borst, G. J., Cramer, M. J., Visseren, F. L. J., van Petersen, R., Dinther, B. G. F., Algra, A., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.002 · Cited by 4
Cited by
Effects of Inclisiran in Patients With Atherosclerotic Cardiovascular Disease
Wright, R. S., Ray, K. K., Landmesser, U., Koenig, W., Raal, F. J., Leiter, L. A., Conde, L. G., Han, J., & Schwartz, G. G. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.03.025 · Cited by 25
Decreased expression of the GLP-1 receptor after segmental artery injury in mice
Bjørnholm, K. D., Povlsen, G. K., Ougaard, M. E., Pyke, C., Rakipovski, G., Tveden-Nyborg, P., Lykkesfeldt, J., & Skovsted, G. F. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0608 · Cited by 10
Kousios, A., Hadjivasilis, A., Kouis, P., & Panayiotou, A. (2020) · doi:10.21203/rs.3.rs-104160/v1 · Cited by 1
Metadata
- Authors
- Valdivielso, J. M., Rodríguez-Puyol, D., Pascual, J., Barrios, C., Bermúdez-López, M., Sánchez-Niño, M. D., Pérez-Fernández, M., & Ortiz, A.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2019-10
- Volume
- 39
- Issue
- 10
- Pages
- 1938-1966
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2969064380
- Cited by
- 305
- References
- 270
- FWCI
- 19.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.